Top Markets
#1 Helium Helium +109.80%
#2 MowCat MowCat +84.82%
#3 Seeker Seeker +49.80%
#4 UnifAI Network UnifAI Network +35.50%
#5 TENDIES TENDIES +30.52%
#6 Zylo Ecosystem Zylo Ecosystem +22.07%
#7 Tensor Tensor +21.07%
#8 Pons Pons +19.96%
#9 MarsCoin MarsCoin +17.58%
#10 pipedog pipedog +16.58%
Coin of the day
Helium Helium
설정
언어
한국어
통화
USD
테마
Senores Pharmaceuticals Ltd. Senores Pharmaceuticals Ltd.

Senores Pharmaceuticals Ltd.

SENORES
주식 순위 #11030
Established in 2017 and headquartered in Ahmedabad, India, Senores... Established in 2017 and headquartered in Ahmedabad, India, Senores Pharmaceuticals Ltd. is actively involved in the development, manufacturing, and global commercialization of pharmaceutical and related products. Its extensive portfolio reaches markets across India, the United States, the United Kingdom, Canada, and other international territories. The company specializes in a diverse array of therapeutic solutions, encompassing analgesics/antipyretics, anesthetics, antibacterials, antivirals, antifungals, antioxidants, antineoplastics, blood-related therapies, cardiovascular and neurological medications, antacids, and vitamin and mineral supplements. Additionally, Senores offers a selection of generic drugs targeting pain, inflammation, fever, diabetes, malaria, and urinary tract conditions, as well as neutral supplements. Complementing its product offerings, the firm also provides management and consultancy services.
주가
$16.36
마지막 동기화: 2026-08-28
시가총액
$753.27M
변동 (1일)
0.51%
변동 (1년)
108.95%
국가
IN
거래 Senores Pharmaceuticals Ltd. (SENORES)

카테고리

Healthcare
Senores Pharmaceuticals Ltd. (SENORES)의 수익
2026 기준 수익 TTM: 0
Senores Pharmaceuticals Ltd.의 최신 재무 보고서에 따르면 회사의 현재 수익은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 수익 0과 동일입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Senores Pharmaceuticals Ltd.의 수익 기록 (2026 ~ 2026)
연말 수익
연도 수익 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -
US